{
  "resourceType": "Bundle",
  "id": "levemir-ePI-annotated-time",
  "type": "document",
  "meta": {
    "profile": [
      "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Bundle-epi"
    ]
  },
  "identifier": {
    "system": "https://www.gravitatehealth.eu/sid/doc",
    "value": "levemir-epi-time-annotated"
  },
  "language": "en",
  "entry": [
    {
      "fullUrl": "Composition/levemir-epi-time",
      "resource": {
        "resourceType": "Composition",
        "id": "levemir-epi-time",
        "status": "final",
        "type": {
          "coding": [
            {
              "system": "http://loinc.org",
              "code": "60591-5",
              "display": "Patient summary Document"
            }
          ],
          "text": "Package leaflet – Levemir"
        },
        "title": "Levemir package leaflet (time-effect annotated)",
        "date": "2024-12-11",
        "language": "en",
        "subject": {
          "reference": "Medication/levemir",
          "display": "Levemir 100 units/mL solution for injection"
        },
        "author": [
          {
            "display": "Novo Nordisk A/S (EPAR leaflet); time-effect annotation for Gravitate-Health demo"
          }
        ],
        "section": [
          {
            "title": "Time-effect profile of Levemir",
            "code": {
              "text": "Time-effect of insulin detemir"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Levemir (insulin detemir) is a long-acting basal insulin with a relatively flat time-action profile.</p><ul><li><b>Onset of action:</b> approximately 3–4 hours after subcutaneous injection.</li><li><b>Peak effect:</b> no pronounced peak; glucose-lowering effect is relatively flat over the dosing interval.</li><li><b>Duration of action:</b> up to about 24 hours depending on dose, injection site and individual response.</li></ul></div>"
            },
            "extension": [
              {
                "url": "http://gravitatehealth.eu/fhir/StructureDefinition/time-effect-annotation",
                "extension": [
                  {
                    "url": "onset",
                    "valueRange": {
                      "low": {
                        "value": 3,
                        "unit": "hours",
                        "system": "http://unitsofmeasure.org",
                        "code": "h"
                      },
                      "high": {
                        "value": 4,
                        "unit": "hours",
                        "system": "http://unitsofmeasure.org",
                        "code": "h"
                      }
                    }
                  },
                  {
                    "url": "peak",
                    "valueString": "No pronounced peak; relatively flat profile over the dosing interval."
                  },
                  {
                    "url": "duration",
                    "valueRange": {
                      "low": {
                        "value": 16,
                        "unit": "hours",
                        "system": "http://unitsofmeasure.org",
                        "code": "h"
                      },
                      "high": {
                        "value": 24,
                        "unit": "hours",
                        "system": "http://unitsofmeasure.org",
                        "code": "h"
                      }
                    }
                  }
                ]
              }
            ]
          },
          {
            "title": "Factors that increase Levemir effect (risk of hypoglycaemia)",
            "code": {
              "text": "Dose-increasing / effect-increasing factors"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Situations from the leaflet that can <b>increase</b> the blood-glucose-lowering effect of Levemir and therefore may require <b>dose reduction</b> or extra carbohydrate intake:</p><ul><li>Injecting too much insulin compared with your needs.</li><li>Eating too little or skipping a meal.</li><li>Unplanned or more intense physical activity than usual.</li><li>Drinking alcohol.</li><li>Improvements in insulin sensitivity (for example after recovery from illness or weight loss).</li></ul></div>"
            },
            "extension": [
              {
                "url": "http://gravitatehealth.eu/fhir/StructureDefinition/time-effect-annotation",
                "extension": [
                  {
                    "url": "effectDirection",
                    "valueCode": "increased"
                  },
                  {
                    "url": "clinicalConsequence",
                    "valueString": "Higher risk of hypoglycaemia; consider reducing dose and/or increasing carbohydrate intake around the time of maximum effect."
                  }
                ]
              }
            ]
          },
          {
            "title": "Factors that reduce Levemir effect (risk of hyperglycaemia)",
            "code": {
              "text": "Dose-decreasing / effect-reducing factors"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Situations from the leaflet that can <b>reduce</b> the blood-glucose-lowering effect of Levemir and therefore may require a <b>dose increase</b> or correction insulin:</p><ul><li>Forgetting insulin doses or injecting less than prescribed.</li><li>Eating more than usual or frequent snacking.</li><li>Less physical activity than usual.</li><li>Concomitant illness, infection, fever or major stress that increases insulin requirement.</li><li>Changes in concomitant medicines that raise blood glucose.</li></ul></div>"
            },
            "extension": [
              {
                "url": "http://gravitatehealth.eu/fhir/StructureDefinition/time-effect-annotation",
                "extension": [
                  {
                    "url": "effectDirection",
                    "valueCode": "reduced"
                  },
                  {
                    "url": "clinicalConsequence",
                    "valueString": "Higher risk of hyperglycaemia and ketoacidosis; consider increasing basal dose or adding correction insulin as clinically appropriate."
                  }
                ]
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "Medication/levemir",
      "resource": {
        "resourceType": "Medication",
        "id": "levemir",
        "code": {
          "coding": [
            {
              "system": "http://www.whocc.no/atc",
              "code": "A10AE05",
              "display": "insulin detemir"
            }
          ],
          "text": "Levemir 100 units/mL solution for injection"
        },
        "form": {
          "coding": [
            {
              "system": "http://standardterms.edqm.eu",
              "code": "111115",
              "display": "Solution for injection"
            }
          ]
        }
      }
    }
  ]
}